News from the FDA/CDC

Adult diabetes up 35% over 25 years


 

The overall prevalence of diabetes increased 35% from 1988-1994 to 2011-2014 among adults aged 20 years and over, according the National Center for Health Statistics.

During 2011-2014, the age-adjusted prevalence of diabetes was 11.9% in adults aged 20 years and over, compared with 8.8% in 1988-1994. That 35% increase came despite a decrease in undiagnosed diabetes from 3.6% to 2.9% over that time period, which was not enough to offset a jump in physician-diagnosed disease from 5.2% to 9%, the NCHS reported in “Health, United States, 2016.”

Diabetes prevalence among adults aged 20 years and over
Although diabetes prevalence was up for each of the largest racial/ethnic groups, only the increase from 7.7% to 9.6% in non-Hispanic whites was statistically significant. Prevalence in non-Hispanic blacks rose from 16.3% to 18% from 1988-1994 to 2011-2014, and adults of Mexican origin saw an increase from 15.6% to 18%. Neither change was statistically significant, the NCHS said.

Undiagnosed diabetes dropped from 2.9% to 2% in whites and from 7.2% to 4.6% in blacks, but adults of Mexican origin saw a slight increase from 5% in 1988-1994 to 5.1% in 2011-2014. The physician-diagnosed side of the equation rose from 4.8% to 7.6% in whites, 9.1% to 13.4% in blacks, and 10.7% to 13% in those of Mexican origin, according to data from the National Health and Nutrition Examination Survey, which combines interviews and physical examinations, including laboratory analysis of blood samples.

Recommended Reading

In PCOS, too much sitting means higher glucose levels
Clinician Reviews
Which Diet for Type 2 Diabetes?
Clinician Reviews
Small study: Vitamin D repletion may decrease insulin resistance
Clinician Reviews
Is Diabetes Distress on Your Radar Screen?
Clinician Reviews
Routine blood glucose monitoring does not improve control or QOL
Clinician Reviews
REMOVAL: Metformin may reduce cardiac risk in type 1 diabetes but doesn’t improve glucose control
Clinician Reviews
Providers buck lipid recommendations in high-risk diabetes
Clinician Reviews
DEVOTE: Degludec and glargine had similar risk with less severe hypoglycemia
Clinician Reviews
How Low Should You Go? Optimizing BP in CKD
Clinician Reviews
Insulin degludec decreases rate, severity of hypoglycemic episodes
Clinician Reviews

Related Articles